Experimental coronavirus treatment remdesivir shows promise in study where two thirds of patients improved
Two thirds of seriously ill Covid-19 patients saw their condition improve after receiving the experimental drug remdesivir, according to a study sponsored by its developer Gilead Sciences.The drug was originally developed to treat diseases such as Ebola and has since been found to have antiviral qualities.In a study published in the New England Journal of Medicine on Saturday, Gilead Science said clinical trials had been carried out among 53 patients.“We cannot draw definitive conclusions from…
A 65-year-old malaria drug that has not been proven to work against the new coronavirus but was touted by Donald Trump appears to have captured the imagination of another president.France’s Emmanuel Macron unexpectedly flew to Marseille on Thursday and spent more than three hours meeting with Didier Raoult, the researcher whose work has propelled a medicine called hydroxychloroquine from fringe to famous in just three weeks. Raoult’s unconventional studies won over US President Trump, who…
In a press conference, President Donald Trump said a drug called chloroquine could be a "game-changer" in treating coronavirus. Dr. Anthony Fauci, National Institute of Allergy and Infectious Diseases Director, says he doesn't think it was described that way.